News

Our drug discovery platform win the Start Tel Aviv Competition

 Aug, 29th 2016

Enzymlogic is heading to Israel in September to represent Spain in one of the most incredible start-up economies in the world.


Start Tel Aviv is a global competition held by The Israeli Ministry of Foreign Affairs and Tel Aviv Global that takes place in 31 countries in order to find the best startups in the world. The Start Tel Aviv experience will take place in September 25-29 and  participants will have the opportunity to meet the coolest and smartest companies, techies, startups, scientists, investors, and culture creators from Israel and abroad.

This global recognition proof that our vision and drug discovery solutions are making a big difference in the market. We are very excited for the opportunity to build international relations with top entrepreneurs from over 30 countries around the world and showcase what Enzymlogic is doing on the global stage.


About Enzymlogic

Enzymlogic offers in vitro biochemical and cell-based assays to the biotechnological and pharmaceutical companies, life science laboratories and academic groups. Our binding kinetics, kinetic selectivity, assay development, profiling and screening services enable faster and cost-effective drug discovery by identifying the most promising drug candidates as well as withdrawing those compounds likely to fail in pre-clinical development. Additionally, Enzymlogic’s pioneering approach provides predictive tools that deliver physiologically relevant insights earlier in the drug discovery process.

Back